Purchase Order 75N98F23P00018

Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village,...

Medgenome Inc. was awarded a $3,789.68 firm fixed price purchase order by the Department of the Interior's United States Geological Survey Office of Acquisitions and Grants. The contract calls for the delivery of HMW DNA extraction services to be performed in Foster City, California by September 23, 2021. As a small business, Medgenome Inc. has consistently provided genomic sequencing, laboratory testing, and DNA/RNA extraction services to federal agencies such as the Department of Health and...

Genedx, LLC was awarded a $10.5K firm fixed-price call under a Blanket Purchase Agreement (BPA) by the National Cancer Institute for germline mutation testing and variant validation in inherited bone marrow failure syndromes. The contract, awarded on July 12, 2018, with an ultimate completion date of May 22, 2023, represents a specialized procurement supporting the NCI's research and clinical objectives. The work was performed at Genedx's laboratory facilities in Potomac, Maryland. This award...

This firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer (a civilian agency), a component of the National Institutes of Health (NIH), to Genedx, LLC, a for-profit limited liability company. The $81,666 contract is for medical laboratory testing services, specifically genetic testing and diagnostic services. Genedx, a wholly owned subsidiary of Opko Health, Inc., provides comprehensive genetic testing, including mutation analysis, exome and genome...

The U.S. government awarded a purchase order valued at $22,816.72 to 10X Genomics, Inc. on June 25, 2021, with an ultimate completion date of August 4, 2021. This firm fixed-price contract, which includes $100 in shipping charges, was funded by a civilian federal agency within the Northeast Area and references Quote No. SQ3114069V1 provided by John Cigoni on May 27, 2021. The work is to be performed in Orient, New York. No set-aside designation was used for this procurement. 10X Genomics,...

This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute to Genedx, LLC, a subsidiary of Opko Health, Inc. The $25,000.00 firm fixed-price purchase order is for the provision of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing. The contract has a completion date of June 30, 2025. Genedx is the prime...

This is a firm fixed-price purchase order contract awarded by the Office of the Chief Operating Officer at the National Institutes of Health (NIH) to Genedx, LLC, a for-profit limited liability company, for medical laboratory testing services. The contract award, valued at $97,833.65, has a performance period from January 14, 2016, to an ultimate completion date of the same day. Genedx, a wholly owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic...

This is a federal contract award to 10X Genomics, Inc., a biotechnology company based in Pleasanton, California. The award, valued at $20,476.37, is a Blanket Purchase Agreement (BPA) call order under a larger indefinite delivery contract (IDC) with the National Institute on Deafness and Other Communication Disorders (NIDCD), part of the National Institutes of Health (NIH). The contract is for the provision of GEM-X UNIVERSAL 3' GENE EXPRESSION V4 systems, which are specialized genomic...

Seqgen, Inc., an Asian-Pacific American minority-owned business based in Torrance, California, was awarded a firm fixed-price purchase order valued at $2,900 by the Plains Area office of a civilian federal agency for one-year maintenance services on an ABI 3730 genetic analyzer. The contract, awarded on September 9, 2019, with an ultimate completion date of September 14, 2020, was issued without a set-aside designation and will be performed in Manhattan, Kansas. This maintenance agreement, based...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Firm Fixed Price Purchase Order to GenScript USA Inc., a for-profit biotechnology company, to provide DETECTION OF MUTATION-REACTIVE T CELLS IN PATIENTS WITH METASTATIC CANCERS. The contract has a potential value of $849,989.66 and a completion date of September 21, 2019. The contract does not have a set-aside designation. GenScript USA Inc. has a history of providing customized DNA,...